Regulatory Affairs Market Size, Share & Trends Report

Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By Categories, By Service Provider, By Company Size, By Product Stage, By Indication, By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-4-68039-065-9
  • Number of Pages: 175
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Table of Content

Chapter 1. Regulatory Affairs Market: Research Methodology And Scope
                   1.1. Market Segmentation & Scope
                       1.1.1. Segment Definitions
                       1.1.2. Services
                       1.1.3. Categories
                       1.1.4. Indication
                   1.2. Regional Scope
                   1.3. Estimates And Forecast Timeline
                   1.4. Objectives
                       1.4.1. Objective - 1
                       1.4.2. Objective - 2
                       1.4.3. Objective - 3
                   1.5. Research Methodology
                   1.6. Information Procurement
                       1.6.1. Purchased Database
                       1.6.2. GVR’s Internal Database
                       1.6.3. Secondary Sources
                       1.6.4. Primary Research
                   1.7. Information Or Data Analysis
                       1.7.1. Data Analysis Models
                   1.8. Market Formulation & Validation
                   1.9. Model Details
                       1.9.1. Commodity Flow Analysis
                       1.9.2. Parent Market Analysis
                   1.10. List Of Secondary Sources
                   1.11. List Of Abbreviations
Chapter 2. Regulatory Affairs Market: Executive Summary
                   2.1. Market Outlook
                   2.2. Segment Outlook
                   2.3. Competitive Insights
Chapter 3. Regulatory Affairs Market: Variables, Trends & Scope
                   3.1. Market Lineage Outlook
                       3.1.1. Parent Market Outlook
                       3.1.2. Related/Ancillary Market Outlook
                   3.2. Market Dynamics
                       3.2.1. Market Driver Analysis
                           3.2.1.1. Changing Regulatory Landscape
                           3.2.1.2. Entry Of Companies Into The Global Market
                           3.2.1.3. Life Science Companies Focusing On Their Core Competencies
                           3.2.1.4. Economic And Competitive Pressures
                           3.2.1.5. Demand For The Faster Approval Process For Breakthrough Drugs And Devices
                           3.2.1.6. Growth In Emerging Areas Such As Personalized Medicine, Biosimilars, And Orphan Drugs
                       3.2.2. Market Restraint Analysis
                           3.2.2.1. Risk Associated With Data Security
                           3.2.2.2. Monitoring Issues And Lack Of Standardization
                           3.2.3. Industry Challenges
                           3.2.3.1. Managing Relationships
                       3.2.4. Major Deals and Strategic Alliances Analysis
                           3.2.4.1. Acquisition
                           3.2.4.2. Joint Venture
                           3.2.4.3. Expansions
                           3.2.4.4. Partnerships & Collaborations
                           3.2.4.5. Technology Advancements & Service Launches
                       3.2.5. Major Deals and Strategic Alliances Analysis of Biotech & Advanced Therapy Medicinal Products (ATMPs)
                   3.3. Regulatory Affairs Market Analysis Tools
                       3.3.1. Industry Analysis - Porter’s
                           3.3.1.1. Supplier Power
                           3.3.1.2. Buyer Power
                           3.3.1.3. Substitution Threat
                           3.3.1.4. Threat Of New Entrant
                           3.3.1.5. Competitive Rivalry
                       3.3.2. PESTEL Analysis
                       3.3.3. SWOT Analysis
                       3.3.4. COVID-19 Impact Analysis
                           3.3.4.1. COVID-19 Impact on Clinical Trials Services
                           3.3.4.2. COVID-19 Impact on Regulatory Services
                           3.3.4.3. COVID-19 Impact on Key Players
                               3.3.4.3.1. Medpace
                               3.3.4.3.2. Icon Plc
                               3.3.4.3.3. Charles River Laboratories
                               3.3.4.3.4. Labcorp Drug Development
                           3.3.4.4. Post COVID-19 Market Scenario
Chapter 4. Regulatory Affairs Market: Services Estimates & Trend Analysis
                   4.1. Regulatory Affairs Market, By Services: Segment Dashboard
                   4.2. Regulatory Affairs Market, By Services: Movement Analysis
                   4.3. Regulatory Affairs Market Estimates & Forecasts, By Services, 2018 - 2030
                       4.3.1. Regulatory Consulting
                           4.3.1.1. Regulatory Consulting Regulatory Affairs Market, 2018 to 2030 (USD Million)
                       4.3.2. Legal Representation
                           4.3.2.1. Legal Representation Regulatory Affairs Market, 2018 to 2030 (USD Million)
                       4.3.3. Regulatory Writing and Publishing
                           4.3.3.1. Regulatory Writing and Publishing Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           4.3.3.2. Writing
                               4.3.3.2.1. Writing Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           4.3.3.3. Publishing
                               4.3.3.3.1. Publishing Regulatory Affairs Market, 2018 to 2030 (USD Million)
                       4.3.4. Product Registration and Clinical Trial Application
                           4.3.4.1. Product Registration and Clinical Trial Application Regulatory Affairs Market, 2018 to 2030 (USD Million)
                       4.3.5. Other Regulatory Services
                           4.3.5.1. Other Regulatory Services Regulatory Affairs Market, 2018 to 2030 (USD Million)
Chapter 5. Regulatory Affairs Market: Categories Estimates & Trend Analysis
                   5.1. Regulatory Affairs Market, By Categories: Segment Dashboard
                   5.2. Regulatory Affairs Market, By Categories: Movement Analysis
                   5.3. Regulatory Affairs Market Estimates & Forecasts, By Categories, 2018 - 2030
                       5.3.1. Drugs
                           5.3.1.1. Drugs Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           5.3.1.2. Innovator
                               5.3.1.2.1. Innovator Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.1.2.2. Preclinical
                                   5.3.1.2.2.1. Preclinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.1.2.3. Clinical
                                   5.3.1.2.3.1. Clinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.1.2.4. PMA
                                   5.3.1.2.4.1. PMA Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           5.3.1.3. Generics
                               5.3.1.3.1. Generics Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.1.3.2. Preclinical
                                   5.3.1.3.2.1. Preclinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.1.3.3. Clinical
                                   5.3.1.3.3.1. Clinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.1.3.4. PMA
                                   5.3.1.3.4.1. PMA Regulatory Affairs Market, 2018 to 2030 (USD Million)
                       5.3.2. Biologics
                           5.3.2.1. Biologics Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           5.3.2.2. Biotech
                               5.3.2.2.1. Biotech Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.2.2. Preclinical
                                   5.3.2.2.2.1. Preclinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.2.3. Clinical
                                   5.3.2.2.3.1. Clinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.2.4. PMA
                                   5.3.2.2.4.1. PMA Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           5.3.2.3. ATMP
                               5.3.2.3.1. ATMP Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.3.2. Preclinical
                                   5.3.2.3.2.1. Preclinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.3.3. Clinical
                                   5.3.2.3.3.1. Clinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.3.4. PMA
                                   5.3.2.3.4.1. PMA Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           5.3.2.4. Biosimilars
                               5.3.2.4.1. Biosimilars Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.4.2. Preclinical
                                   5.3.2.4.2.1. Preclinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.4.3. Clinical
                                   5.3.2.4.3.1. Clinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.2.4.4. PMA
                                   5.3.2.4.4.1. PMA Regulatory Affairs Market, 2018 to 2030 (USD Million)
                       5.3.3. Medical Devices
                           5.3.3.1. Medical Devices Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           5.3.3.2. Diagnostics
                               5.3.3.2.1. Diagnostics Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.3.2.2. Preclinical
                                   5.3.3.2.2.1. Preclinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.3.2.3. Clinical
                                   5.3.3.2.3.1. Clinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.3.2.4. PMA
                                   5.3.3.2.4.1. PMA Regulatory Affairs Market, 2018 to 2030 (USD Million)
                           5.3.3.3. Therapeutics
                               5.3.3.3.1. Therapeutics Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.3.3.2. Preclinical
                                   5.3.3.3.2.1. Preclinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.3.3.3. Clinical
                                   5.3.3.3.3.1. Clinical Regulatory Affairs Market, 2018 to 2030 (USD Million)
                               5.3.3.3.4. PMA
                                   5.3.3.3.4.1. PMA Regulatory Affairs Market, 2018 to 2030 (USD Million)
Chapter 6. Regulatory Affairs Market: Indication Estimates & Trend Analysis
                   6.1. Regulatory Affairs Market, By Indication: Segment Dashboard
                   6.2. Regulatory Affairs Market, By Indication: Movement Analysis
                   6.3. Regulatory Affairs Market Estimates & Forecasts, By Indication, 2018 - 2030
                       6.3.1. Oncology
                           6.3.1.1. Oncology Regulatory Affairs Market 2018 to 2030 (USD Million)
                       6.3.2. Neurology
                           6.3.2.1. Neurology Regulatory Affairs Market 2018 to 2030 (USD Million)
                       6.3.3. Cardiology
                           6.3.3.1. Cardiology Regulatory Affairs Market 2018 to 2030 (USD Million)
                       6.3.4. Hematology
                           6.3.4.1. Hematology Regulatory Affairs Market 2018 to 2030 (USD Million)
                       6.3.5. Immunology
                           6.3.5.1. Immunology Regulatory Affairs Market 2018 to 2030 (USD Million)
                       6.3.6. Others
                           6.3.6.1. Others Regulatory Affairs Market 2018 to 2030 (USD Million)
Chapter 7. Regulatory Affairs Market: Service Provider Segment Estimates & Trend Analysis
                   7.1. Regulatory Affairs Market, By Service Provider Segment: Segment Dashboard
                   7.2. Regulatory Affairs Market, By Service Provider Segment: Movement Analysis
                   7.3. Regulatory Affairs Market Estimates & Forecasts, By Service Provider Segment, 2018 - 2030
                       7.3.1. In-house
                           7.3.1.1. In-house Regulatory Affairs Market 2018 to 2030 (USD Million)
                       7.3.2. Outsourcing
                           7.3.2.1. Outsourcing Regulatory Affairs Market 2018 to 2030 (USD Million)
Chapter 8. Regulatory Affairs Market: Company Size Estimates & Trend Analysis
                   8.1. Regulatory Affairs Market, By Company Size: Segment Dashboard
                   8.2. Regulatory Affairs Market, By Company Size: Movement Analysis
                   8.3. Regulatory Affairs Market Estimates & Forecasts, By Company Size, 2018 - 2030
                       8.3.1. Small-sized
                           8.3.1.1. Small-sized Regulatory Affairs Market 2018 to 2030 (USD Million)
                       8.3.2. Medium-sized
                           8.3.2.1. Medium-sized Regulatory Affairs Market 2018 to 2030 (USD Million)
                       8.3.3. Large Companies
                           8.3.3.1. Large Companies Regulatory Affairs Market 2018 to 2030 (USD Million)
Chapter 9. Regulatory Affairs Market: Product Stage Estimates & Trend Analysis
                   9.1. Regulatory Affairs Market, By Product Stage: Segment Dashboard
                   9.2. Regulatory Affairs Market, By Product Stage: Movement Analysis
                   9.3. Regulatory Affairs Market Estimates & Forecasts, By Product Stage, 2018 - 2030
                       9.3.1. Preclinical
                           9.3.1.1. Preclinical Regulatory Affairs Market 2018 to 2030 (USD Million)
                       9.3.2. Clinical
                           9.3.2.1. Clinical Regulatory Affairs Market 2018 to 2030 (USD Million)
                       9.3.3. PMA
                           9.3.3.1. PMA Regulatory Affairs Market 2018 to 2030 (USD Million)
Chapter 10. Regulatory Affairs Market: End-use Estimates & Trend Analysis
                   10.1. Regulatory Affairs Market, By End-use: Segment Dashboard
                   10.2. Regulatory Affairs Market, By End-use: Movement Analysis
                   10.3. Regulatory Affairs Market Estimates & Forecasts, By End-use, 2018 - 2030
                       10.3.1. Medical Device Companies
                           10.3.1.1. Medical Device Companies Regulatory Affairs Market 2018 to 2030 (USD Million)
                       10.3.2. Pharmaceutical Companies
                           10.3.2.1. Pharmaceutical Companies Regulatory Affairs Market 2018 to 2030 (USD Million)
                       10.3.3. Biotechnology Companies
                           10.3.3.1. Biotechnology Companies Regulatory Affairs Market 2018 to 2030 (USD Million)
Chapter 11. Regulatory Affairs Market: Regional Estimates & Trend Analysis
                   11.1. Regional Market Share Analysis, 2022 & 2030
                   11.2. Regional Market Dashboard
                   11.3. Global Regional Market Snapshot
                   11.4. North America
                       11.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
                       11.4.2. U.S.
                           11.4.2.1. Key Country Dynamics
                           11.4.2.2. Competitive Scenario
                           11.4.2.3. Regulatory Framework
                           11.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
                       11.4.3. Canada
                           11.4.3.1. Key Country Dynamics
                           11.4.3.2. Competitive Scenario
                           11.4.3.3. Regulatory Framework
                           11.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
                   11.5. Europe
                       11.5.1. UK
                           11.5.1.1. Key Country Dynamics
                           11.5.1.2. Competitive Scenario
                           11.5.1.3. Regulatory Framework
                           11.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
                       11.5.2. Germany
                           11.5.2.1. Key Country Dynamics
                           11.5.2.2. Competitive Scenario
                           11.5.2.3. Regulatory Framework
                           11.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
                       11.5.3. France
                           11.5.3.1. Key Country Dynamics
                           11.5.3.2. Competitive Scenario
                           11.5.3.3. Regulatory Framework
                           11.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
                       11.5.4. Italy
                           11.5.4.1. Key Country Dynamics
                           11.5.4.2. Competitive Scenario
                           11.5.4.3. Regulatory Framework
                           11.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
                       11.5.5. Spain
                           11.5.5.1. Key Country Dynamics
                           11.5.5.2. Competitive Scenario
                           11.5.5.3. Regulatory Framework
                           11.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
                       11.5.6. Russia
                           11.5.6.1. Key Country Dynamics
                           11.5.6.2. Competitive Scenario
                           11.5.6.3. Regulatory Framework
                           11.5.6.4. Russia Market Estimates and Forecasts, 2018 - 2030
                       11.5.7. Turkey
                           11.5.7.1. Key Country Dynamics
                           11.5.7.2. Competitive Scenario
                           11.5.7.3. Regulatory Framework
                           11.5.7.4. Turkey Market Estimates and Forecasts, 2018 - 2030
                       11.5.8. Netherlands
                           11.5.8.1. Key Country Dynamics
                           11.5.8.2. Competitive Scenario
                           11.5.8.3. Regulatory Framework
                           11.5.8.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
                       11.5.9. Switzerland
                           11.5.9.1. Key Country Dynamics
                           11.5.9.2. Competitive Scenario
                           11.5.9.3. Regulatory Framework
                           11.5.9.4. Switzerland Market Estimates and Forecasts, 2018 - 2030
                       11.5.10. Sweden
                           11.5.10.1. Key Country Dynamics
                           11.5.10.2. Competitive Scenario
                           11.5.10.3. Regulatory Framework
                           11.5.10.4. Sweden Market Estimates and Forecasts, 2018 - 2030
                   11.6. Asia Pacific
                       11.6.1. Japan
                           11.6.1.1. Key Country Dynamics
                           11.6.1.2. Competitive Scenario
                           11.6.1.3. Regulatory Framework
                           11.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
                       11.6.2. India
                           11.6.2.1. Key Country Dynamics
                           11.6.2.2. Competitive Scenario
                           11.6.2.3. Regulatory Framework
                           11.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
                       11.6.3. China
                           11.6.3.1. Key Country Dynamics
                           11.6.3.2. Competitive Scenario
                           11.6.3.3. Regulatory Framework
                           11.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
                       11.6.4. South Korea
                           11.6.4.1. Key Country Dynamics
                           11.6.4.2. Competitive Scenario
                           11.6.4.3. Regulatory Framework
                           11.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
                       11.6.5. Australia
                           11.6.5.1. Key Country Dynamics
                           11.6.5.2. Competitive Scenario
                           11.6.5.3. Regulatory Framework
                           11.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
                       11.6.6. Thailand
                           11.6.6.1. Key Country Dynamics
                           11.6.6.2. Competitive Scenario
                           11.6.6.3. Regulatory Framework
                           11.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
                       11.6.7. Indonesia
                           11.6.7.1. Key Country Dynamics
                           11.6.7.2. Competitive Scenario
                           11.6.7.3. Regulatory Framework
                           11.6.7.4. Indonesia Market Estimates and Forecasts, 2018 - 2030
                       11.6.8. Malaysia
                           11.6.8.1. Key Country Dynamics
                           11.6.8.2. Competitive Scenario
                           11.6.8.3. Regulatory Framework
                           11.6.8.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
                       11.6.9. Singapore
                           11.6.9.1. Key Country Dynamics
                           11.6.9.2. Competitive Scenario
                           11.6.9.3. Regulatory Framework
                           11.6.9.4. Singapore Market Estimates and Forecasts, 2018 - 2030
                       11.6.10. Taiwan
                           11.6.10.1. Key Country Dynamics
                           11.6.10.2. Competitive Scenario
                           11.6.10.3. Regulatory Framework
                           11.6.10.4. Taiwan Market Estimates and Forecasts, 2018 - 2030
                   11.7. Latin America
                       11.7.1. Brazil
                           11.7.1.1. Key Country Dynamics
                           11.7.1.2. Competitive Scenario
                           11.7.1.3. Regulatory Framework
                           11.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
                       11.7.2. Mexico
                           11.7.2.1. Key Country Dynamics
                           11.7.2.2. Competitive Scenario
                           11.7.2.3. Regulatory Framework
                           11.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
                       11.7.3. Argentina
                           11.7.3.1. Key Country Dynamics
                           11.7.3.2. Competitive Scenario
                           11.7.3.3. Regulatory Framework
                           11.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
                       11.7.4. Colombia
                           11.7.4.1. Key Country Dynamics
                           11.7.4.2. Competitive Scenario
                           11.7.4.3. Regulatory Framework
                           11.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
                       11.7.5. Chile
                           11.7.5.1. Key Country Dynamics
                           11.7.5.2. Competitive Scenario
                           11.7.5.3. Regulatory Framework
                           11.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
                   11.8. Middle East & Africa
                       11.8.1. South Africa
                           11.8.1.1. Key Country Dynamics
                           11.8.1.2. Competitive Scenario
                           11.8.1.3. Regulatory Framework
                           11.8.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
                       11.8.2. Saudi Arabia
                           11.8.2.1. Key Country Dynamics
                           11.8.2.2. Competitive Scenario
                           11.8.2.3. Regulatory Framework
                           11.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
                       11.8.3. UAE
                           11.8.3.1. Key Country Dynamics
                           11.8.3.2. Competitive Scenario
                           11.8.3.3. Regulatory Framework
                           11.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
                       11.8.4. Egypt
                           11.8.4.1. Key Country Dynamics
                           11.8.4.2. Competitive Scenario
                           11.8.4.3. Regulatory Framework
                           11.8.4.4. Egypt Market Estimates and Forecasts, 2018 - 2030
                       11.8.5. Israel
                           11.8.5.1. Key Country Dynamics
                           11.8.5.2. Competitive Scenario
                           11.8.5.3. Regulatory Framework
                           11.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030
Chapter 12. Competitive Landscape
                   12.1. Market Participant Categorization
                       12.1.1. Innovators
                       12.1.2. Market Leaders
                       12.1.3. Emerging Players
                       12.1.4. Company Market Share Analysis, 2022
                   12.2. Company Profiles
                       12.2.1. Accell Clinical Research, LLC
                           12.2.1.1. Company Overview
                           12.2.1.2. Financial Performance
                           12.2.1.3. Service Benchmarking
                           12.2.1.4. Strategic Initiatives
                       12.2.2. Genpact
                           12.2.2.1. Company Overview
                           12.2.2.2. Financial Performance
                           12.2.2.3. Service Benchmarking
                           12.2.2.4. Strategic Initiatives
                       12.2.3. Criterium, Inc.
                           12.2.3.1. Company Overview
                           12.2.3.2. Financial Performance
                           12.2.3.3. Service Benchmarking
                           12.2.3.4. Strategic Initiatives
                       12.2.4. ICON plc
                           12.2.4.1. Company Overview
                           12.2.4.2. Financial Performance
                           12.2.4.3. Service Benchmarking
                           12.2.4.4. Strategic Initiatives
                       12.2.5. Promedica International
                           12.2.5.1. Company Overview
                           12.2.5.2. Financial Performance
                           12.2.5.3. Service Benchmarking
                           12.2.5.4. Strategic Initiatives
                       12.2.6. WuXi AppTec
                           12.2.6.1. Company Overview
                           12.2.6.2. Financial Performance
                           12.2.6.3. Service Benchmarking
                           12.2.6.4. Strategic Initiatives
                       12.2.7. Medpace
                           12.2.7.1. Company Overview
                           12.2.7.2. Financial Performance
                           12.2.7.3. Service Benchmarking
                           12.2.7.4. Strategic Initiatives
                       12.2.8. Charles River Laboratories
                           12.2.8.1. Company Overview
                           12.2.8.2. Financial Performance
                           12.2.8.3. Service Benchmarking
                           12.2.8.4. Strategic Initiatives
                       12.2.9. Labcorp Drug Development
                           12.2.9.1. Company Overview
                           12.2.9.2. Financial Performance
                           12.2.9.3. Service Benchmarking
                           12.2.9.4. Strategic Initiatives
                       12.2.10. Parexel International Corporation
                           12.2.10.1. Company Overview
                           12.2.10.2. Financial Performance
                           12.2.10.3. Service Benchmarking
                           12.2.10.4. Strategic Initiatives
                       12.2.11. Freyr
                           12.2.11.1. Company Overview
                           12.2.11.2. Financial Performance
                           12.2.11.3. Service Benchmarking
                           12.2.11.4. Strategic Initiatives
                       12.2.12. Pharmalex GmbH
                           12.2.12.1. Company Overview
                           12.2.12.2. Financial Performance
                           12.2.12.3. Service Benchmarking
                           12.2.12.4. Strategic Initiatives
                       12.2.13. NDA Group AB
                           12.2.13.1. Company Overview
                           12.2.13.2. Financial Performance
                           12.2.13.3. Service Benchmarking
                           12.2.13.4. Strategic Initiatives
                       12.2.14. Pharmexon
                           12.2.14.1. Company Overview
                           12.2.14.2. Financial Performance
                           12.2.14.3. Service Benchmarking
                           12.2.14.4. Strategic Initiatives
                       12.2.15. Qvigilance
                           12.2.15.1. Company Overview
                           12.2.15.2. Financial Performance
                           12.2.15.3. Service Benchmarking
                           12.2.15.4. Strategic Initiatives
                       12.2.16. BlueReg
                           12.2.16.1. Company Overview
                           12.2.16.2. Financial Performance
                           12.2.16.3. Service Benchmarking
                           12.2.16.4. Strategic Initiatives
                       12.2.17. Cambridge Regulatory Services
                           12.2.17.1. Company Overview
                           12.2.17.2. Financial Performance
                           12.2.17.3. Service Benchmarking
                           12.2.17.4. Strategic Initiatives
                       12.2.18. VCLS
                           12.2.18.1. Company Overview
                           12.2.18.2. Financial Performance
                           12.2.18.3. Service Benchmarking
                           12.2.18.4. Strategic Initiatives
Chapter 13. Kol Commentary/Key Recommendations


List of Tables

Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 Global regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 4 Global regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 5 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 6 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 7 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 8 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 9 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 10 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 11 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 12 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 13 Regulatory affairs market, by Biosimilars, 2018 - 2030 (USD Million)
Table 14 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 15 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 16 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 17 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 18 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 19 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 20 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 21 Global regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 22 North America regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 23 North America regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 24 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 25 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 26 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 27 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 28 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 29 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 30 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 31 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 32 Regulatory affairs market, by Biosimilar, 2018 - 2030 (USD Million)
Table 33 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 34 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 35 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 36 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 37 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 38 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 39 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 40 North America Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 41 U.S. regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 42 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 43 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 44 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 45 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 46 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 47 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 48 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 49 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 50 Regulatory affairs market, by Biosimilar, 2018 - 2030 (USD Million)
Table 51 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 52 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 53 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 54 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 55 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 56 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 57 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 58 U.S. Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 59 Canada regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 60 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 61 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 62 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 63 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 64 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 65 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 66 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 67 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 68 Regulatory affairs market, by Biosimilar, 2018 - 2030 (USD Million)
Table 69 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 70 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 71 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 72 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 73 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 74 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 75 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 76 Canada Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 77 Europe regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 78 Europe regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 79 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 80 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 81 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 82 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 83 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 84 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 85 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 86 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 87 Regulatory affairs market, by Biosimilars, 2018 - 2030 (USD Million)
Table 88 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 89 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 90 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 91 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 92 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 93 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 94 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 95 Europe regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 96 U.K. regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 97 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 98 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 99 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 100 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 101 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 102 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 103 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 104 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 105 Regulatory affairs market, by Biosimilar, 2018 - 2030 (USD Million)
Table 106 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 107 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 108 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 109 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 110 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 111 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 112 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 113 U.K. regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 114 Germany regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 115 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 116 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 117 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 118 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 119 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 120 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 121 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 122 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 123 Regulatory affairs market, by Biosimilars, 2018 - 2030 (USD Million)
Table 124 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 125 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 126 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 127 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 128 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 129 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 130 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 131 Germany regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 132 France regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 133 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 134 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 135 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 136 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 137 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 138 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 139 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 140 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 141 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 142 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 143 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 144 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 145 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 146 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 147 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 148 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 149 France regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 150 Italy regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 151 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 152 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 153 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 154 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 155 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 156 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 157 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 158 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 159 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 160 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 161 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 162 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 163 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 164 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 165 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 166 Italy Regulatory Affairs Market, By End-Use, 2018 - 2030 (USD Million)
Table 167 Spain Regulatory Affairs Market, By Service, 2018 - 2030 (USD Million)
Table 168 Regulatory Affairs Market, By Regulatory Writing & Publishing, 2018 - 2030 (USD Million)
Table 169 Regulatory Affairs Market, By Category, 2018 - 2030 (USD Million)
Table 170 Regulatory Affairs Market, By Drugs, 2018 - 2030 (USD Million)
Table 171 Regulatory Affairs Market, By Innovator, 2018 - 2030 (USD Million)
Table 172 Regulatory Affairs Market, By Generics, 2018 - 2030 (USD Million)
Table 173 Regulatory Affairs Market, By Biologics, 2018 - 2030 (USD Million)
Table 174 Regulatory Affairs Market, By Biotech, 2018 - 2030 (USD Million)
Table 175 Regulatory Affairs Market, By ATMP, 2018 - 2030 (USD Million)
Table 176 Regulatory Affairs Market, By BIOSIMILARS, 2018 - 2030 (USD Million)
Table 177 Regulatory Affairs Market, By Medical Devices, 2018 - 2030 (USD Million)
Table 178 Regulatory Affairs Market, By Diagnostics, 2018 - 2030 (USD Million)
Table 179 Regulatory Affairs Market, By Therapeutics, 2018 - 2030 (USD Million)
Table 180 Regulatory Affairs Market, By Indication, 2018 - 2030 (USD Million)
Table 181 Regulatory Affairs Market, By Product Stage, 2018 - 2030 (USD Million)
Table 182 Regulatory Affairs Market, By Service Provider, 2018 - 2030 (USD Million)
Table 183 Regulatory Affairs Market, By Company Size, 2018 - 2030 (USD Million)
Table 184 Spain Regulatory Affairs Market, By End-Use, 2018 - 2030 (USD Million)
Table 185 Russia Regulatory Affairs Market, By Service, 2018 - 2030 (USD Million)
Table 186 Regulatory Affairs Market, By Regulatory Writing & Publishing, 2018 - 2030 (USD Million)
Table 187 Regulatory Affairs Market, By Category, 2018 - 2030 (USD Million)
Table 188 Regulatory Affairs Market, By Drugs, 2018 - 2030 (USD Million)
Table 189 Regulatory Affairs Market, By Innovator, 2018 - 2030 (USD Million)
Table 190 Regulatory Affairs Market, By Generics, 2018 - 2030 (USD Million)
Table 191 Regulatory Affairs Market, By Biologics, 2018 - 2030 (USD Million)
Table 192 Regulatory Affairs Market, By Biotech, 2018 - 2030 (USD Million)
Table 193 Regulatory Affairs Market, By ATMP, 2018 - 2030 (USD Million)
Table 194 Regulatory Affairs Market, By BIOSIMILARS, 2018 - 2030 (USD Million)
Table 195 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 196 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 197 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 198 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 199 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 200 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 201 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 202 Russia regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 203 Turkey regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 204 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 205 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 206 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 207 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 208 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 209 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 210 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 211 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 212 Table 210 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 213 Table 211 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 214 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 215 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 216 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 217 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 218 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 219 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 220 Turkey regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 221 Netherlands regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 222 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 223 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 224 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 225 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 226 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 227 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 228 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 229 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 230 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 231 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 232 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 233 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 234 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 235 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 236 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 237 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 238 The Netherlands regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 239 Switzerland regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 240 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 241 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 242 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 243 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 244 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 245 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 246 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 247 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 248 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 249 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 250 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 251 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 252 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 253 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 254 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 255 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 256 Switzerland regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 257 Sweden regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 258 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 259 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 260 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 261 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 262 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 263 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 264 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 265 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 266 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 267 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 268 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 269 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 270 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 271 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 272 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 273 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 274 Sweden regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 275 Asia Pacific regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 276 Asia Pacific regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 277 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 278 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 279 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 280 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 281 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 282 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 283 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 284 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 285 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 286 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 287 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 288 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 289 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 290 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 291 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 292 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 293 Asia Pacific Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 294 Japan regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 295 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 296 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 297 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 298 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 299 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 300 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 301 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 302 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 303 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 304 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 305 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 306 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 307 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 308 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 309 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 310 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 311 Japan regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 312 China regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 313 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 314 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 315 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 316 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 317 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 318 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 319 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 320 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 321 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 322 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 323 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 324 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 325 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 326 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 327 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 328 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 329 China regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 330 India regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 331 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 332 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 333 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 334 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 335 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 336 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 337 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 338 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 339 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 340 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 341 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 342 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 343 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 344 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 345 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 346 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 347 India regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 348 Australia regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 349 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 350 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 351 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 352 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 353 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 354 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 355 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 356 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 357 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 358 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 359 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 360 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 361 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 362 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 363 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 364 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 365 Australia regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 366 South Korea regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 367 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 368 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 369 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 370 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 371 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 372 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 373 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 374 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 375 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 376 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 377 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 378 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 379 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 380 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 381 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 382 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 383 South Korea regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 384 Malaysia regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 385 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 386 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 387 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 388 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 389 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 390 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 391 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 392 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 393 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 394 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 395 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 396 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 397 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 398 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 399 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 400 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 401 Malaysia regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 402 Singapore regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 403 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 404 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 405 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 406 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 407 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 408 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 409 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 410 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 411 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 412 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 413 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 414 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 415 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 416 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 417 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 418 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 419 Singapore regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 420 Thailand regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 421 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 422 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 423 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 424 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 425 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 426 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 427 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 428 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 429 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 430 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 431 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 432 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 433 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 434 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 435 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 436 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 437 Thailand regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 438 Taiwan regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 439 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 440 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 441 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 442 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 443 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 444 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 445 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 446 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 447 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 448 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 449 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 450 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 451 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 452 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 453 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 454 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 455 Taiwan regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 456 Latin America regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 457 Latin America regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 458 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 459 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 460 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 461 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 462 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 463 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 464 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 465 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 466 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 467 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 468 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 469 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 470 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 471 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 472 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 473 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 474 Latin America Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 475 Brazil regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 476 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 477 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 478 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 479 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 480 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 481 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 482 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 483 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 484 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 485 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 486 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 487 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 488 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 489 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 490 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 491 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 492 Brazil regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 493 Mexico regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 494 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 495 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 496 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 497 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 498 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 499 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 500 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 501 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 502 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 503 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 504 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 505 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 506 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 507 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 508 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 509 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 510 Mexico regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 511 Argentina regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 512 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 513 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 514 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 515 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 516 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 517 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 518 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 519 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 520 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 521 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 522 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 523 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 524 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 525 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 526 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 527 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 528 Argentina regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 529 Colombia regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 530 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 531 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 532 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 533 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 534 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 535 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 536 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 537 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 538 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 539 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 540 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 541 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 542 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 543 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 544 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 545 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 546 Colombia regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 547 Chile regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 548 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 549 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 550 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 551 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 552 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 553 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 554 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 555 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 556 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 557 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 558 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 559 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 560 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 561 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 562 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 563 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 564 Chile regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 565 South Africa regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 566 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 567 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 568 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 569 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 570 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 571 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 572 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 573 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 574 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 575 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 576 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 577 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 578 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 579 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 580 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 581 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 582 South Africa regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 583 Saudi Arabia regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 584 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 585 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 586 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 587 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 588 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 589 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 590 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 591 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 592 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 593 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 594 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 595 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 596 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 597 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 598 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 599 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 600 Saudi Arabia regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 601 UAE regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 602 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 603 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 604 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 605 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 606 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 607 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 608 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 609 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 610 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 611 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 612 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 613 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 614 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 615 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 616 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 617 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 618 UAE regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 619 Egypt regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 620 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 621 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 622 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 623 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 624 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 625 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 626 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 627 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 628 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 629 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 630 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 631 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 632 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 633 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 634 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 635 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 636 Egypt regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 637 Israel regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 638 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 639 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 640 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 641 Regulatory affairs market, by Innovator, 2018 - 2030 (USD Million)
Table 642 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 643 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 644 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 645 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 646 Regulatory affairs market, by BIOSIMILARS, 2018 - 2030 (USD Million)
Table 647 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 648 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 649 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 650 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 651 Regulatory affairs market, by Product Stage, 2018 - 2030 (USD Million)
Table 652 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 653 Regulatory affairs market, by Company Size, 2018 - 2030 (USD Million)
Table 654 Israel regulatory affairs market, by end-use, 2018 - 2030 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 QFD modeling for market share assessment
Fig. 6 Market formulation & validation
Fig. 10 Regulatory affairs market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Percentage of Clinical Trial Registered in Different Regions (November 2022)
Fig. 13 Personalized medicine approved by the FDA
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 SWOT
Fig. 16 Porter’s five forces analysis
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Usage/adoption of cloud technology for regulatory space
Fig. 19 Regulatory affairs market service outlook: Segment dashboard
Fig. 20 Regulatory affairs market: service movement analysis
Fig. 21 Regulatory consulting market, 2018 - 2030 (USD Million)
Fig. 22 Legal representation market, 2018 - 2030 (USD Million)
Fig. 23 Regulatory writing and publishing market, 2018 - 2030 (USD Million)
Fig. 24 Product registration and clinical trial application market, 2018 - 2030 (USD Million)
Fig. 25 Other regulatory services market, 2018 - 2030 (USD Million)
Fig. 26 Regulatory affairs market service provider outlook: Segment dashboard
Fig. 27 Regulatory affairs market: service provider movement analysis
Fig. 28 In-house regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 29 Outsourcing regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 30 Regulatory affairs market company size outlook: Segment dashboard
Fig. 31 Regulatory affairs market: Company size movement analysis
Fig. 32 Small companies based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 33 Medium sized company based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 34 Large companies based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 35 Regulatory affairs market categories outlook: Segment dashboard
Fig. 36 Regulatory affairs market: Categories movement analysis
Fig. 37 Drugs based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 38 Biologics based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 39 Medical devices based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 40 Regulatory affairs product stage outlook: Segment dashboard
Fig. 41 Regulatory affairs market: Product stage movement analysis
Fig. 42 Preclinical based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 43 Clinical based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 44 PMA based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 45 Regulatory affairs market indication outlook: Segment dashboard
Fig. 46 Regulatory affairs market: indication movement analysis
Fig. 47 Oncology based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 48 Neurology based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 49 Cardiology based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 50 Immunology indication based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 51 Other indication based regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 52 Regulatory affairs market end-use outlook: Segment dashboard
Fig. 53 Regulatory affairs market: end-use movement analysis
Fig. 54 Medical device companies market, 2018 - 2030 (USD Million)
Fig. 55 Pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 56 Biotechnology companies market, 2018 - 2030 (USD Million)
Fig. 57 Regional market: Key takeaways
Fig. 58 Regional outlook, 2021 & 2030
Fig. 59 North America market, 2018 - 2030 (USD Million)
Fig. 60 U.S. market, 2018 - 2030 (USD Million)
Fig. 61 Canada market, 2018 - 2030 (USD Million)
Fig. 62 Europe market, 2018 - 2030 (USD Million)
Fig. 63 UK market, 2018 - 2030 (USD Million)
Fig. 64 Germany market, 2018 - 2030 (USD Million)
Fig. 65 France market, 2018 - 2030 (USD Million)
Fig. 66 Italy market, 2018 - 2030 (USD Million)
Fig. 67 Spain market, 2018 - 2030 (USD Million)
Fig. 68 Russia market, 2018 - 2030 (USD Million)
Fig. 69 Turkey market, 2018 - 2030 (USD Million)
Fig. 70 Netherlands market, 2018 - 2030 (USD Million)
Fig. 71 Switzerland market, 2018 - 2030 (USD Million)
Fig. 72 Sweden market, 2018 - 2030 (USD Million)
Fig. 73 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 74 Japan market, 2018 - 2030 (USD Million)
Fig. 75 China market, 2018 - 2030 (USD Million)
Fig. 76 India market, 2018 - 2030 (USD Million)
Fig. 77 Australia market, 2018 - 2030 (USD Million)
Fig. 78 South Korea market, 2018 - 2030 (USD Million)
Fig. 79 Indonesia market, 2018 - 2030 (USD Million)
Fig. 80 Malaysia market, 2018 - 2030 (USD Million)
Fig. 81 Singapore market, 2018 - 2030 (USD Million)
Fig. 82 Thailand market, 2018 - 2030 (USD Million)
Fig. 83 Taiwan market, 2018 - 2030 (USD Million)
Fig. 84 Latin America market, 2018 - 2030 (USD Million)
Fig. 85 Brazil market, 2018 - 2030 (USD Million)
Fig. 86 Mexico market, 2018 - 2030 (USD Million)
Fig. 87 Argentina market, 2018 - 2030 (USD Million)
Fig. 88 Colombia market, 2018 - 2030 (USD Million)
Fig. 89 Chile market, 2018 - 2030 (USD Million)
Fig. 90 MEA market, 2018 - 2030 (USD Million)
Fig. 91 South Africa market, 2018 - 2030 (USD Million)
Fig. 92 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 93 UAE market, 2018 - 2030 (USD Million)
Fig. 94 Egypt market, 2018 - 2030 (USD Million)
Fig. 95 Israel market, 2018 - 2030 (USD Million)
Fig. 96 Key Strategies
Fig. 97 Market participant categorization
Fig. 98 Organization Structure - Accell Clinical Research, LLC
Fig. 99 SWOT - Accell Clinical Research, LLC
Fig. 100 Financial performance of Genpact
Fig. 101 Organization Structure - Genpact Ltd
Fig. 102 SWOT - Genpact
Fig. 103 Organization Structure - Criterium, Inc.
Fig. 104 SWOT -CRITERIUM, INC.
Fig. 105 Organization Structure - Promedica International
Fig. 106 SWOT - Promedica International
Fig. 107 Financial performance of WuXi AppTec
Fig. 108 Organization Structure -WuXi AppTec
Fig. 109 SWOT - Wuxi AppTec
Fig. 110 Financial performance of Medspace
Fig. 111 Organization Structure - Medpace
Fig. 112 SWOT - Medpace
Fig. 113 Financial performance of Charles River Laboratories
Fig. 114 Organization Structure - Charles River Laboratories International, Inc.
Fig. 115 SWOT - Charles River Laboratories International, Inc
Fig. 116 Financial performance of ICON plc
Fig. 117 Organization Structure - ICON plc
Fig. 118 SWOT - ICON plc
Fig. 119 Financial performance of Laboratory Corporation of America Holdings
Fig. 120 Organization Structure -Laboratory Corporation of America Holdings
Fig. 121 SWOT - Laboratory Corporation of America Holdings
Fig. 122 Organization Structure - PAREXEL International Corporation
Fig. 123 SWOT - Parexel International Corporation
Fig. 124 Organization Structure - Freyr
Fig. 125 SWOT - Freyr

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon